BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Summary

BMS-275291 may stop the growth of prostate cancer by stopping blood flow to the tumor and by blocking the enzymes necessary for tumor cell growth. Randomized phase II trial to study the effectiveness of BMS-275291 in treating patients who have prostate cancer that has not responded to hormone therapy

Timeline

Start

2002-05

Primary completion

2006-07

Completion

—

Drugs

Indications